We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Alza Drops Patent Suit Over ADHD Drug

Law360 (October 3, 2006, 12:00 AM EDT) -- Pharmaceutical firm Alza Corp., a unit of Johnson & Johnson, dropped its patent infringement lawsuit Tuesday against generic drug maker Impax Laboratories Inc. over Alza’s treatment for attention deficit disorder.

Alza filed the lawsuit after Impax sought permission from the U.S. Food and Drug Administration to make a generic version of the drug Concerta. Impax said Alza’s patents for the drug aren’t valid.

The dismissal came as a surprising reversal for Alza’s parent company, J&J. The health care giant filed the lawsuit in September 2005 in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.